Foundayo vs. Compounded Semaglutide: Cost, Efficacy, and the Compounding Patient's Calculus
In April 2026, the FDA approved Foundayo (orforglipron) — the first oral GLP-1 pill with no food, water, or timing restrictions. For patients currently on compounded semaglutide, this creates a new question: is it time to switch to an FDA-approved oral option?
Here's a direct comparison across the factors that actually matter.
Head-to-Head Comparison
| Factor | Foundayo (Orforglipron) | Compounded Injectable Semaglutide |
|---|---|---|
| FDA approved | Yes | No |
| Format | Daily pill | Weekly injection |
| Weight loss (72wk) | 7.5–11.2% | ~15% (same molecule as Wegovy) |
| Food/water rules | None | N/A (injection) |
| Storage | Room temp (protect from light) | Refrigerate |
| Regulatory risk | None — FDA-approved | Ongoing — 503B exclusion pending, 503A under scrutiny |
| Monthly cost | Brand pricing (TBD) | $99–$299/mo |
| Medicare Bridge eligible | Yes ($50/mo) | No |
| Insurance coverage | Expanding | None |
When Compounded Still Wins
Cost without insurance: At $99–$149/month through telehealth providers, compounded semaglutide remains significantly cheaper than any brand-name GLP-1 without insurance coverage. If you're paying cash and Foundayo's brand pricing lands at $500+/month (likely), the math still favors compounded.
Weight loss efficacy: Compounded semaglutide delivers the same molecule as Wegovy, which achieves ~15% weight loss at 72 weeks. Foundayo's maximum was 11.2%. For patients who need maximum weight reduction, injectable semaglutide still delivers more.
Dose flexibility: Compounding pharmacies can create custom titration schedules and doses not available in commercial products. Some patients benefit from non-standard dose steps.
When Foundayo Wins
Regulatory certainty: No risk of supply disruption from regulatory action. The compounded GLP-1 landscape is shifting fast — Foundayo will be available regardless.
No injections: For needle-averse patients, a daily pill eliminates the biggest barrier to starting treatment.
Medicare coverage: Starting July 1, 2026, Medicare covers Foundayo at $50/month through the GLP-1 Bridge. Compounded medications are excluded.
Travel convenience: No refrigeration, no sharps, no explaining vials at airport security. Just a pill bottle.
The Decision Framework
Compounded Providers to Compare
Brand-Name Access
Compare Compounding Pharmacy Providers
See pricing, pharmacy type, and what's included — side by side.
Compare Providers →